Immuron (IMRN) Common Equity (2016 - 2025)
Immuron (IMRN) posted quarterly Common Equity of $80318.3 for Q3 2025, down 36.8% year-over-year from $127094.4 in Q3 2024, and down 98.45% quarter-over-quarter from $5.2 million in Q2 2025.
Immuron (IMRN) Common Equity (2016 - 2025) Analysis & Trends
Immuron's Common Equity history runs 10 years deep, the most recent figure standing at $80318.3 for Q3 2025.
- In Q3 2025, Common Equity fell 36.8% year-over-year to $80318.3; the TTM figure through Sep 2025 stood at $80318.3 (down 36.8% YoY), while the FY2025 annual figure was $80318.3, down 36.8% from the prior year.
- Common Equity for Q3 2025 stood at $80318.3, down from $5.2 million in the prior quarter.
- The five-year high for Common Equity was $19.9 million in Q2 2021, with the low at $80318.3 in Q3 2025.
- The 5-year median for Common Equity is $10.6 million (2024), against an average of $9.5 million.
- The sharpest annual moves came in 2021 and 2023: Common Equity surged 6541.63% in 2021, then sank 99.25% in 2023.
- Immuron's Common Equity stood at $19.0 million in 2021, then retreated by 19.66% to $15.2 million in 2022, then tumbled by 99.25% to $114095.9 in 2023, then jumped by 5826.24% to $6.8 million in 2024, then sank by 98.81% to $80318.3 in 2025.
- Business Quant data shows IMRN's Common Equity at $80318.3 in Q3 2025, $5.2 million in Q2 2025, and $6.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | 80,318.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 80,318.33 |
| Jun 30, 2025 | 5.17 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 9, 2024 | 127,094.44 |
| Jun 30, 2024 | 8.38 Mn |
| Dec 31, 2023 | 114,095.94 |
| Sep 28, 2023 | 12.86 Mn |
| Aug 30, 2023 | 196,168.36 |
| Jun 30, 2023 | 13.11 Mn |
| Dec 31, 2022 | 15.23 Mn |
| Aug 31, 2022 | 16.12 Mn |
| Jun 30, 2022 | 16.60 Mn |
| Dec 31, 2021 | 18.96 Mn |
| Jun 30, 2021 | 19.94 Mn |
| Dec 31, 2020 | 285,406.46 |
| Sep 1, 2020 | 5.64 Mn |
| Jun 30, 2020 | 3.70 Mn |
| Dec 31, 2019 | 56,439.13 |
| Jun 30, 2019 | 5.15 Mn |
| Dec 31, 2018 | 8.44 Mn |